Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 1, 2011, Pages 133-136

  Park, Han Sang ^a   Nam, Ki Yup ^b   Kim, Jung Yeul ^b,c  

^a Kyungpook National University School of Medicine   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

Intravitreal bevacizumab; Serous retinal detachment; Vogt Koyanagi Harada disease

Indexed keywords

BEVACIZUMAB; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; DRUG MEGADOSE; EYE PAIN; FEMALE; HEADACHE; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; SEROUS RETINAL DETACHMENT; VISUAL ACUITY; VISUAL IMPAIRMENT; VOGT KOYANAGI SYNDROME;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COLORING AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INTRAVITREAL INJECTIONS; METHYLPREDNISOLONE; PULSE THERAPY, DRUG; RETINAL DETACHMENT; TOMOGRAPHY, OPTICAL COHERENCE; UVEOMENINGOENCEPHALITIC SYNDROME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 79951724490     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1477-8     Document Type: Article

References (9)

1. Nussenblatt RB (2004) Vogt-Koyanagi-Harada syndrome. In: Nussenblatt RB, Whitcup SM (eds) Uveitis fundamentals and clinical practice, 3rd edn. CV Mosby, St. Louis, pp 324-338
2. EB Rodrigues ME Farah M Maia FM Penha C Regatieri GB Melo MM Pinheiro CR Zanetti 2009 Therapeutic monoclonal antibodies in ophthalmology Prog Retin Eye Res 28 117 144 1:CAS:528:DC%2BD1MXhvFGks7k%3D 10.1016/j.preteyeres.2008.11.005 19114125
3. E Yamanaka N Ohguro S Yamamoto Y Nakagawa Y Imoto Y Tano 2002 Evaluation of pulse corticosteroid therapy for Vogt-Koyanagi-Harada disease assessed by optical coherence tomography Am J Ophthalmol 134 454 456 1:CAS:528: DC%2BD38Xms1Kgurw%3D 10.1016/S0002-9394(02)01575-1 12208266
4. RE Andrade C Muccioli ME Farah RB Nussenblatt R Belfort Jr 2004 Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome Am J Ophthalmol 137 572 574 10.1016/j.ajo.2003.08. 035 15013890 (Pubitemid 38328658)
5. S Young G Larkin M Branley S Lightman 2001 Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis Clin Experiment Ophthalmol 29 2 6 1:STN:280:DC%2BD3M7nt1Glug%3D%3D 10.1046/j.1442-9071.2001. 00360.x 11272779 (Pubitemid 32170788)
6. M Cordero Coma L Sobrin S Onal W Christen CS Foster 2007 Intravitreal bevacizumab for treatment of uveitic macular edema Ophthalmology 114 1574 1579 10.1016/j.ophtha.2006.11.028 17363060 (Pubitemid 47126590)
7. HF Fine J Baffi GF Reed KG Csaky RB Nussenblatt 2001 Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoids macular edema Am J Ophthalmol 132 794 796 1:CAS:528:DC%2BD3MXotFWhsLk%3D 10.1016/S0002-9394(01)01103-5 11704050 (Pubitemid 33031303)
8. MN Lott JC Schiffman JL Davis 2009 Bevacizumab in inflammatory eye disease Am J Ophthalmol 149 711 717 10.1016/j.ajo.2009.06.010
9. SJ Lim MI Roh OW Kwon 2010 Intravitreal bevacizumab injection for central serous chorioretinopathy Retina 30 100 106 10.1097/IAE.0b013e3181bcf0b4 20010322